This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Acorda Therapeutics, Inc.. Active years: 2013-2020.
Company Filing History:
Years Active: 2013-2020
Title: Haesun Kim: Innovator in Glial Growth Factor Research
Introduction
Haesun Kim is a notable inventor based in Teaneck, NJ (US), recognized for his contributions to the field of biomedical research. He holds a total of four patents, showcasing his innovative approach to addressing medical challenges.
Latest Patents
Among his latest patents is a method for achieving desired glial growth factor 2 (GGF2) plasma levels. This invention relates to administering GGF2 to patients in need, aiming to achieve serum levels within a therapeutic window tailored to the specific disease or disorder affecting the patient. In particular, this method is beneficial for patients suffering from conditions associated with reduced levels of myelination, as GGF2 is administered to promote myelination.
Career Highlights
Haesun Kim is currently associated with Acorda Therapeutics, Inc., where he continues to advance his research and innovations. His work focuses on developing therapeutic strategies that leverage the potential of glial growth factors in treating neurological disorders.
Collaborations
One of his notable coworkers is Anthony O Caggiano, with whom he collaborates on various research initiatives aimed at enhancing patient outcomes through innovative therapies.
Conclusion
Haesun Kim's contributions to the field of glial growth factor research exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds the potential to improve the lives of patients facing neurological challenges.